HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Traynor, B. J. Articles by Hardiman, O. Search for Related Content PubMed PubMed Citation Articles by Traynor, B. J. Articles by Hardiman, O.

Incidence and prevalence of ALS in Ireland, 1995–1997

A population-based study

From the Department of Neurology (Drs. Traynor and Hardiman, and B. Corr and C. Forde), National Neuroscience Center for Ireland, Beaumont Hospital; the Department of Epidemiology and Biostatistics (Dr. Codd), Mater Misericordiae Hospital; and the Irish Motor Neuron Disease Association (E. Frost), Dublin, Ireland.

Address correspondence and reprint requests to Dr. Orla Hardiman, Department of Neuroscience, National Neuroscience Center for Ireland, Beaumont Hospital, Dublin, Ireland.

BACKGROUND: We conducted a prospective, population-based study of ALS in the Republic of Ireland for the 3-year period 1995 to 1997.

METHODS: To ensure complete case ascertainment, multiple sources of information were used, including consultant neurologists, neurophysiologists, primary care physicians, and the Irish Motor Neuron Disease Association. The El Escorial diagnostic criteria for ALS were applied to all cases enrolled on the register and each patient was regularly followed up during his or her illness.

RESULTS: Between January 1, 1995, and December 31, 1997, 231 patients were diagnosed with possible, probable, or definite ALS, including 133 men (57.6%) and 98 women (42.4%). The average annual incidence rate was 2.1 per 100,000 person-years (95% CI, 1.8 to 2.4), and 2.8 per 100,000 person-years for the population older than 15 years (95% CI, 2.4 to 3.1). The incidence rate was higher for men, being 2.5 per 100,000 person-years (95% CI, 2.0 to 2.9), than for women, at 1.8 per 100,000 person-years (95% CI, 1.5 to 2.2), and increased with age for both sexes. The median age at onset was 64.2 years for men and 67.8 years for women. On December 31, 1996, the crude prevalence was 4.7 per 100,000 of the total population (95% CI, 4.0 to 5.5), and 6.2 per 100,000 for the population older than 15 years (95% CI, 5.3 to 7.1). Adjusting to the 1996 Irish population as standard, the incidence of ALS in Ireland during the 3-year study period is the third highest reported to date.

CONCLUSIONS: There was a trend toward a higher incidence of ALS in the northwestern region of Ireland, although the numbers of cases involved were small and further study is required.

This article has been cited by other articles:

				F. Fang, U. Valdimarsdottir, R. Bellocco, L.-O. Ronnevi, P. Sparen, K. Fall, and W. Ye Amyotrophic Lateral Sclerosis in Sweden, 1991-2005 Arch Neurol, April 1, 2009; 66(4): 515 - 519. [Abstract] [Full Text] [PDF]

				M. Murphy, S. Quinn, J. Young, P. Parkin, and B. Taylor Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study Neurology, December 2, 2008; 71(23): 1889 - 1895. [Abstract] [Full Text] [PDF]

				M. Sabatelli, F. Madia, A. Conte, M. Luigetti, M. Zollino, I. Mancuso, M. Lo Monaco, G. Lippi, and P. Tonali Natural history of young-adult amyotrophic lateral sclerosis Neurology, September 16, 2008; 71(12): 876 - 881. [Abstract] [Full Text] [PDF]

				G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 6 - 11. [Abstract] [Full Text] [PDF]

				O O'Toole, B J Traynor, P Brennan, C Sheehan, E Frost, B Corr, and O Hardiman Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004 J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 30 - 32. [Abstract] [Full Text] [PDF]

				J H Veldink, S Kalmijn, G-J Groeneveld, W Wunderink, A Koster, J H M de Vries, J van der Luyt, J H J Wokke, and L H Van den Berg Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 367 - 371. [Abstract] [Full Text] [PDF]

				S. Cronin, O. Hardiman, and B. J. Traynor Ethnic variation in the incidence of ALS: A systematic review Neurology, March 27, 2007; 68(13): 1002 - 1007. [Abstract] [Full Text] [PDF]

				D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky How common are the "common" neurologic disorders? Neurology, January 30, 2007; 68(5): 326 - 337. [Abstract] [Full Text] [PDF]

				E. Beghi, A. Millul, A. Micheli, E. Vitelli, G. Logroscino, and for the SLALOM Group Incidence of ALS in Lombardy, Italy Neurology, January 9, 2007; 68(2): 141 - 145. [Abstract] [Full Text] [PDF]

				G. N. O'Neill, R. G. Gonzalez, D. P. Cros, R. H. Ackerman, R. H. Brown Jr., and A. Stemmer-Rachamimov Case records of the Massachusetts General Hospital. Case 22-2006--a 77-year-old man with a rapidly progressive gait disorder. N. Engl. J. Med., July 20, 2006; 355(3): 296 - 304. [Full Text] [PDF]

				G. Levy, P. Kaufmann, R. Buchsbaum, J. Montes, A. Barsdorf, R. Arbing, V. Battista, X. Zhou, H. Mitsumoto, B. Levin, et al. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS Neurology, March 14, 2006; 66(5): 660 - 663. [Abstract] [Full Text] [PDF]

				J. P. Van den Berg, S. Kalmijn, E. Lindeman, J. H. Veldink, M. de Visser, M. M. Van der Graaff, J.H.J. Wokke, and L. H. Van den Berg Multidisciplinary ALS care improves quality of life in patients with ALS Neurology, October 25, 2005; 65(8): 1264 - 1267. [Abstract] [Full Text] [PDF]

				J. H. Veldink, S. Kalmijn, A. H. Van der Hout, H. H. Lemmink, G. J. Groeneveld, C. Lummen, H. Scheffer, J.H.J. Wokke, and L. H. Van den Berg SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS Neurology, September 27, 2005; 65(6): 820 - 825. [Abstract] [Full Text] [PDF]

				G Logroscino, E Beghi, S Zoccolella, R Palagano, A Fraddosio, I L Simone, P Lamberti, V Lepore, L Serlenga, and the SLAP registry Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1094 - 1098. [Abstract] [Full Text] [PDF]

				A. Chio, G. Benzi, M. Dossena, R. Mutani, and G. Mora Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players Brain, March 1, 2005; 128(3): 472 - 476. [Abstract] [Full Text] [PDF]

				J. H. Veldink, S. Kalmijn, G. J. Groeneveld, M. J. Titulaer, J. H.J. Wokke, and L. H. van den Berg Physical activity and the association with sporadic ALS Neurology, January 25, 2005; 64(2): 241 - 245. [Abstract] [Full Text] [PDF]

				M. J. Greenway, M. D. Alexander, S. Ennis, B. J. Traynor, B. Corr, E. Frost, A. Green, and O. Hardiman A novel candidate region for ALS on chromosome 14q11.2 Neurology, November 23, 2004; 63(10): 1936 - 1938. [Abstract] [Full Text] [PDF]

				M. M. Maxwell, P. Pasinelli, A. G. Kazantsev, and R. H. Brown Jr. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells PNAS, March 2, 2004; 101(9): 3178 - 3183. [Abstract] [Full Text] [PDF]

				R. W. Haley Excess incidence of ALS in young Gulf War veterans Neurology, September 23, 2003; 61(6): 750 - 756. [Abstract] [Full Text] [PDF]

				B J Traynor, M Alexander, B Corr, E Frost, and O Hardiman Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000 J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1258 - 1261. [Abstract] [Full Text] [PDF]

				P.G. Ince, J. Evans, M. Knopp, G. Forster, H.H.M. Hamdalla, S.B. Wharton, and P.J. Shaw Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS Neurology, April 22, 2003; 60(8): 1252 - 1258. [Abstract] [Full Text] [PDF]

				J. Mandrioli, P. Faglioni, E. Merelli, and P. Sola The epidemiology of ALS in Modena, Italy Neurology, February 25, 2003; 60(4): 683 - 689. [Abstract] [Full Text] [PDF]

				K Talbot Motor neurone disease Postgrad. Med. J., September 1, 2002; 78(923): 513 - 519. [Abstract] [Full Text] [PDF]

				E. J. Sorenson, A. P. Stalker, L. T. Kurland, and A. J. Windebank Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998 Neurology, July 23, 2002; 59(2): 280 - 282. [Abstract] [Full Text] [PDF]

				J. H. Veldink, J. H.J. Wokke, G. van der Wal, J.M.B. Vianney de Jong, and L. H. van den Berg Euthanasia and Physician-Assisted Suicide among Patients with Amyotrophic Lateral Sclerosis in the Netherlands N. Engl. J. Med., May 23, 2002; 346(21): 1638 - 1644. [Abstract] [Full Text] [PDF]

				Incidence of ALS in Italy: Evidence for a uniform frequency in Western countries Neurology, January 23, 2001; 56(2): 239 - 244. [Abstract] [Full Text] [PDF]

				B. J. Traynor, M. B. Codd, B. Corr, C. Forde, E. Frost, and O. M. Hardiman Clinical Features of Amyotrophic Lateral Sclerosis According to the El Escorial and Airlie House Diagnostic Criteria: A Population-Based Study Arch Neurol, August 1, 2000; 57(8): 1171 - 1176. [Abstract] [Full Text] [PDF]

				B. J. Traynor, M. B. Codd, B. Corr, C. Forde, E. Frost, and O. Hardiman Amyotrophic Lateral Sclerosis Mimic Syndromes: A Population-Based Study Arch Neurol, January 1, 2000; 57(1): 109 - 113. [Abstract] [Full Text] [PDF]